Pictet Asset Management SA increased its holdings in shares of CareTrust REIT, Inc. (NASDAQ:CTRE – Get Rating) by 10.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,251 shares of the real estate investment trust’s stock after acquiring an additional 3,595 shares during the period. Pictet Asset Management SA’s holdings in CareTrust REIT were worth $724,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of CTRE. Quadrant Capital Group LLC raised its holdings in CareTrust REIT by 297.7% in the first quarter. Quadrant Capital Group LLC now owns 1,754 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 1,313 shares during the last quarter. SeaCrest Wealth Management LLC purchased a new position in CareTrust REIT in the second quarter worth about $61,000. MBM Wealth Consultants LLC raised its holdings in CareTrust REIT by 45.7% in the first quarter. MBM Wealth Consultants LLC now owns 3,460 shares of the real estate investment trust’s stock worth $67,000 after buying an additional 1,085 shares during the last quarter. Samalin Investment Counsel LLC purchased a new position in CareTrust REIT in the first quarter worth about $69,000. Finally, US Bancorp DE raised its holdings in CareTrust REIT by 16.2% in the first quarter. US Bancorp DE now owns 7,204 shares of the real estate investment trust’s stock worth $139,000 after buying an additional 1,006 shares during the last quarter. Institutional investors own 83.99% of the company’s stock.
CareTrust REIT Stock Performance
Shares of NASDAQ CTRE opened at $19.27 on Wednesday. The firm has a 50 day moving average of $18.40 and a 200 day moving average of $19.10. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $1.87 billion, a price-to-earnings ratio of -481.75 and a beta of 1.11. CareTrust REIT, Inc. has a 12-month low of $15.90 and a 12-month high of $23.59.
CareTrust REIT Announces Dividend
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on CTRE shares. Barclays decreased their target price on shares of CareTrust REIT from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, October 21st. StockNews.com started coverage on shares of CareTrust REIT in a report on Wednesday, October 12th. They issued a “hold” rating for the company. Finally, Raymond James decreased their target price on shares of CareTrust REIT from $23.00 to $22.00 and set a “strong-buy” rating for the company in a report on Tuesday, November 1st. Five investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.92.
CareTrust REIT Company Profile
CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.
- Get a free copy of the StockNews.com research report on CareTrust REIT (CTRE)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Want to Get a 10% Dividend Yield, Look Here
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
Receive News & Ratings for CareTrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareTrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.